46
Participants
Start Date
October 31, 2013
Primary Completion Date
August 31, 2015
Study Completion Date
September 30, 2015
Carfilzomib
Carfilzomib was administered by IV injection over 30 minutes
Karmanos Cancer Institute, Detroit
Duke Cancer Institute, Durham
Gabrail Cancer Center, Canton
Tennessee Oncology, PLLC, Nashville
Evergreen Hematology and Oncology, Spokane
Institut Gustave Roussy, Paris
University Medical Centre Utrecht, Utrecht
Northern Ireland Cancer Trials Centre - Queen's University Belfast TriaIs Centre, Belfast
Beatson West of Scotland Cancer Centre, Glasgow
Velindre Hospital, Cardlff
Sir Bobby Robson Cancer Trials Research Centre, Newcastle
Lead Sponsor
Amgen
INDUSTRY